Alois Walder

560 total citations
6 papers, 377 citations indexed

About

Alois Walder is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Alois Walder has authored 6 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Alois Walder's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Advanced Breast Cancer Therapies (1 paper). Alois Walder is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Advanced Breast Cancer Therapies (1 paper). Alois Walder collaborates with scholars based in Austria, United Kingdom and Italy. Alois Walder's co-authors include E R Blake, H B Hewitt, Michael Steurer, Michael Fiegl, Richard Greil, Werner Linkesch, Alois Lang, Paul R. Rhomberg, Patrizia Mondello and Michael Mian and has published in prestigious journals such as British Journal of Cancer, Journal of Clinical Virology and Annals of Hematology.

In The Last Decade

Alois Walder

6 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alois Walder Austria	4	228	166	86	62	54	6	377
Maria Liljefors Sweden	12	243 1.1×	224 1.3×	133 1.5×	30 0.5×	85 1.6×	20	451
G Weil-Hillman United States	12	342 1.5×	163 1.0×	103 1.2×	31 0.5×	62 1.1×	16	452
Jennifer B. Jacob United States	13	293 1.3×	159 1.0×	194 2.3×	61 1.0×	105 1.9×	21	500
Mark J. Dobrzanski United States	15	593 2.6×	339 2.0×	110 1.3×	52 0.8×	41 0.8×	22	709
Masataka Nakamura Japan	8	338 1.5×	168 1.0×	78 0.9×	62 1.0×	29 0.5×	10	452
Yangyi Bao China	9	220 1.0×	229 1.4×	90 1.0×	19 0.3×	42 0.8×	17	346
Gina Scurti United States	11	323 1.4×	281 1.7×	182 2.1×	51 0.8×	30 0.6×	23	539
Yui Harada Japan	11	135 0.6×	136 0.8×	92 1.1×	58 0.9×	40 0.7×	26	324
Nicole Huebener Germany	15	330 1.4×	334 2.0×	227 2.6×	156 2.5×	37 0.7×	24	664
Pamela Beatty United States	12	319 1.4×	224 1.3×	197 2.3×	80 1.3×	50 0.9×	21	509

Countries citing papers authored by Alois Walder

Since Specialization

Citations

This map shows the geographic impact of Alois Walder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alois Walder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alois Walder more than expected).

Fields of papers citing papers by Alois Walder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alois Walder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alois Walder. The network helps show where Alois Walder may publish in the future.

Co-authorship network of co-authors of Alois Walder

This figure shows the co-authorship network connecting the top 25 collaborators of Alois Walder. A scholar is included among the top collaborators of Alois Walder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alois Walder. Alois Walder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Pauli, Franziska Di, Thomas Berger, Alois Walder, et al.. (2014). Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: Case report and review of the literature. Journal of Clinical Virology. 60(4). 424–427. 9 indexed citations

2.

Gamerith, Gabriele, Florian Kocher, Patrizia Mondello, et al.. (2014). Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial. Annals of Hematology. 94(4). 593–601. 9 indexed citations

3.

Fiegl, Michael, Reinhard Stauder, Michael Steurer, et al.. (2013). Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. Annals of Hematology. 93(2). 267–277. 12 indexed citations

4.

Schmidt, Stefan, Dominik Wolf‎, Josef Thaler, et al.. (2010). First annual report of the Austrian CML registry. Wiener klinische Wochenschrift. 122(19-20). 558–566. 2 indexed citations

5.

Sun, Wanling, Alois Walder, & Michael Fiegl. (2010). Haemolytic anaemia triggered by antitumoural “biological agents” and immunotherapies with monoclonal antibodies: short review of the literature. memo - Magazine of European Medical Oncology. 3(1). 19–22. 1 indexed citations

6.

Hewitt, H B, E R Blake, & Alois Walder. (1976). A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. British Journal of Cancer. 33(3). 241–259. 344 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact